Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$1.62 - $2.79 $1,762 - $3,035
1,088 Added 95.69%
2,225 $5,000
Q3 2023

Oct 30, 2023

BUY
$1.62 - $2.79 $1,762 - $3,035
1,088 Added 95.69%
2,225 $5,000
Q2 2023

May 21, 2024

SELL
$1.66 - $3.4 $44 - $91
-27 Reduced 2.32%
1,137 $2,000
Q2 2023

Jul 27, 2023

SELL
$1.66 - $3.4 $44 - $91
-27 Reduced 2.32%
1,137 $2,000
Q1 2023

May 21, 2024

BUY
$3.08 - $8.73 $893 - $2,531
290 Added 33.18%
1,164 $3,000
Q1 2023

Apr 27, 2023

BUY
$3.08 - $8.73 $893 - $2,531
290 Added 33.18%
1,164 $4,000
Q4 2022

May 21, 2024

BUY
$3.33 - $6.38 $2,910 - $5,576
874 New
874 $4,000
Q4 2022

Jan 31, 2023

BUY
$3.33 - $6.38 $233 - $446
70 Added 8.71%
874 $5,000
Q3 2022

Oct 21, 2022

BUY
$2.43 - $4.51 $1,953 - $3,626
804 New
804 $3,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.